Rapid variant interpretation and reporting for germline and somatic clinical NGS tests
To fulfill the timeliness of genomics-guided precision medicine, molecular diagnostic labs are challenged to rapidly analyze and interpret a growing number of genetic tests with the latest scientific evidence, drug approvals and treatment guidelines in an efficient, yet thorough, manner.
QIAGEN offers expert-curated knowledge, software and services for next-generation sequencing (NGS) data interpretation and reporting to accelerate confident decision making at the point of care.
Solve more cases faster, with data you can trust using HGMD Professional, the de facto standard resource for identifying inherited disease-causing mutations
Expand your clinical interpretation with expert-curated software for variant classification of any assay, covering any indication, on your sequencing platform
Deliver oncologist-ready variant interpretation reports with QCI Interpret One, clinical decision support software with professional interpretation services.
Reimagine your clinical interpretation with same day, expert variant classification services tailored to your oncology panel
Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities
Empower your clinical testing lab with the industry’s most expansive collection of up-to-date biological and clinical findings, delivering two decades of expert-curated evidence
Empower clinicians and their patients to make critical and timely healthcare decisions with the latest publications and clinical evidence
Provide oncologists with the best information needed to make timely, educated decisions about their patients’ cancer treatment plans
From biomarker discovery and validation to trial design and label expansion, QIAGEN Real-World Insights (RWI) helps you bridge the gap between actionable insight and real-world action.